OPEN END TURBO OHNE STOP-LOSS - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000LX3FAN3

Real-time Bid/Ask 09:11:13 27/06/2024 pm IST
0.7 EUR / 0.73 EUR +0.70% Intraday chart for OPEN END TURBO OHNE STOP-LOSS - FRESENIUS MEDICAL CARE
Current month+86.84%
1 month+77.50%
Date Price Change
27/24/27 0.72 +1.41%
26/24/26 0.71 0.00%
25/24/25 0.71 +10.94%
24/24/24 0.64 -14.67%
21/24/21 0.75 +17.19%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 09:05 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer Lang & Schwarz
WKN LX3FAN
ISINDE000LX3FAN3
Date issued 08/09/2023
Strike 42.11
Maturity Unlimited
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.39
Lowest since issue 0.18
Spread 0.03
Spread %4.05%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus